AJP - Endo Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (June 17, 2008). doi:10.1152/ajpendo.90227.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/2/E505    most recent
90227.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MORO, C.
Right arrow Articles by Berlan, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MORO, C.
Right arrow Articles by Berlan, M.
Submitted on February 12, 2008
Revised on May 23, 2008
Accepted on June 10, 2008

Exercise-induced lipid mobilization in subcutaneous adipose tissue is mainly dependent on natriuretic peptides in overweight men

Cedric MORO, Fabien Pillard1, Isabelle de Glisezinski2, Eva Klimcakova, François CRAMPES, Claire THALAMAS, Isabelle Harant, Marie-Adeline MARQUES, Max Lafontan3, and Michel Berlan4*

1 CHU Toulouse
2 IFR-31, Institut de Medecine Moleculaire de Rangueil
3 inserm U 858-I2MR
4 INSERM U 317

* To whom correspondence should be addressed. E-mail: berlan{at}cict.fr.

Involvement of sympathetic nervous system and natriuretic peptides in the control of exercise-induced lipid mobilization was compared in overweight and lean men. Lipid mobilization was determined using local microdialysis during exercise. Subjects performed 35-min exercise bouts at 60% of their maximal oxygen consumption under placebo or after oral tertatolol (a beta-adrenergic receptor (AR) antagonist). Under placebo, exercise increased dialysate glycerol concentration (DGC) in both groups. Phentolamine (alpha-AR antagonist) potentiated exercise-induced lipolysis in overweight but not in lean subjects; the alpha2-antilipolytic effect was only functional in overweight men. After tertatolol administration, the DGC increased similarly during exercise whatever the probe in both groups. Compared to the control probe under placebo, lipolysis was reduced in lean but not in overweight men treated with the beta-AR blocker. Tertatolol reduced plasma NEFA and insulin concentration in both groups at rest. Under placebo or tertatolol, the exercise-induced changes in plasma NEFA, glycerol and insulin concentrations were similar in both groups. Exercise promoted a higher increase in catecholamine and ANP plasma levels after tertatolol administration. In conclusion, the major finding of our study is that in overweight men, in addition to an increased alpha2-antilipolytic effect, the lipid mobilization in SCAT that persists during exercise under beta-blockade is not dependent on catecholamine action. It is related to a concomitant exercise-induced rise in plasma ANP when exercise is performed under tertatolol intake and a decrease in plasma insulin.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.